NeoGenomics Laboratories · 13 hours ago
Senior Advisor, Tax
Maximize your interview chances
BiotechnologyGenetics
Insider Connection @NeoGenomics Laboratories
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Coordinate with internal accounting, finance, and other departments among multiple levels of the organization to gather financial data and work efficiently with outside auditors and advisors with regards to income tax compliance and reporting
Prepare income tax workpaper support for compliance and financial statement reporting
Prepare Federal and State income tax returns, extensions, and quarterly estimated payments
Maintain broad exposure and knowledge of ASC 740 income tax provisions.
Preparing tax provision schedules (Rate Rec, Current tax, Deferred tax, Valuation Allowance, etc.)
Calculating uncertain tax positions (FIN 48)
Reviewing stock-based equity compensation
Reviewing tax disclosures in SEC filings
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelors Degree in Accounting
6+ years of experience (5 years in public accounting +1 year or Industry experience)
Strong tax accounting skills with proficiency in U.S. GAAP
Expertise with Excel formulas and pivot tables (Power Query and VBA a plus)
Ability to interpret legal documents
Preferred
Master’s in Taxation
CPA Certification
General knowledge of international tax; Form 5471, GILTI, FDII, BEAT and transfer pricing
Knowledge of Oracle ERP, HFM
Knowledge of Go Systems RS/One Source
Benefits
Highly competitive benefits with a variety of HMO and PPO options
401k match
Employee Stock Purchase Program
Tuition reimbursement
Leadership development
16 days of paid time off plus holidays
Wellness courses
Highly engaged employee resource groups
Company
NeoGenomics Laboratories
NeoGenomics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$925.9M2021-05-05Post Ipo Equity· $200M
2020-04-30Post Ipo Equity· $125.4M
2020-04-30Post Ipo Debt· $175M
Recent News
2024-11-06
Company data provided by crunchbase